Department of Medicine

A clinical trial supports approval of a new medication to treat moderate-to-severe asthma in children.
April 24, 2023

Study finds early RSV infection linked to significantly increased risk of asthma in children

A Vanderbilt study has found that RSV infection in the first year of life is associated with a significantly increased risk of asthma in children.

By Nancy Humphrey
April 21, 2023

“You’re Not Alone” video series aids in workplace violence prevention

By VUMC News and Communications
April 20, 2023

Theobald appointed Chief of Staff for Corporate Clinical Affairs and SVP for Clinical Affairs

Cecelia Theobald, MD, MPH, has been appointed as Vanderbilt University Medical Center’s Chief of Staff for Corporate Clinical Affairs and Senior Vice President for Clinical Affairs.

By John Howser
April 20, 2023

Genetics and chronic pain

Polygenic risk scores — scores that reflect the influence of common genetic variants — could be used to predict the likelihood of developing chronic overlapping pain conditions and guide biomarker and targeted prevention efforts.

By Bill Snyder
April 19, 2023

Four elected to the American Academy of Arts & Sciences

Four Vanderbilt University faculty members were recently elected to the American Academy of Arts & Sciences.

By Bill Snyder
April 18, 2023

Vanderbilt mourns loss of former Hematology leader Krantz

Sanford Krantz, MD, internationally recognized authority on hematology and erythropoietin and professor of Medicine, Emeritus, died April 13 at his home. He was 89.

By VUMC News and Communications
April 13, 2023

Children’s mystery symptoms may be alpha-gal syndrome

A Vanderbilt study found that some children with mystery digestive symptoms may actually have undiagnosed alpha-gal syndrome, commonly known as the red meat allergy linked to tick bites.
By Nancy Humphrey
April 12, 2023

Research identifies new target that may prevent blood cancer

An international coalition of biomedical researchers co-led by Vanderbilt's Alexander Bick, MD, PhD, has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients’ risk of blood cancer.
By Bill Snyder
April 6, 2023

COVID-19’s lingering impact on health

A decline in cardiovascular fitness — measured by activity trackers in the All of Us research program — persisted among some groups even after COVID-related restrictions were relaxed, exacerbating health disparities.
By Bill Snyder
April 6, 2023

System repairs donor lungs for transplantation

A Vanderbilt team has discovered that donor lungs rejected for transplant can be repaired using cross-circulation with a xenogeneic host.
By Matt Batcheldor
April 6, 2023

National Cancer Institute honors Berlin’s contributions, leadership

Vanderbilt's Jordan Berlin, MD, is a 2022 recipient of the National Cancer Institute Director’s Award.
By Tom Wilemon
April 6, 2023

A ‘supermere’ method for biomarker discovery

Vanderbilt researchers have developed a method for isolating extracellular vesicles and nanoparticles — a complex transport system involved in health and disease — which will improve biomarker discovery and the identification of therapeutic targets.
By Bill Snyder
April 4, 2023

Vanderbilt receives $1 million in funding for electric vehicle research

Vanderbilt has received funding for two projects that will examine the benefits of and barriers to widespread use of electric vehicles and potential public health impacts of EV adoption.
By VUMC News and Communications
1 … 20 21 22 23 24 … 117